Prenetics Global Limited
PRE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $24 | $18 | $17 | $10 |
| % Growth | 33.2% | 2.1% | 65.1% | – |
| Cost of Goods Sold | $10 | $10 | $10 | $7 |
| Gross Profit | $14 | $7 | $7 | $4 |
| % Margin | 59.5% | 41.2% | 42.4% | 37.2% |
| R&D Expenses | $1 | $1 | $2 | $3 |
| G&A Expenses | $10 | $10 | $11 | $17 |
| SG&A Expenses | $19 | $16 | $16 | $19 |
| Sales & Mktg Exp. | $10 | $5 | $5 | $2 |
| Other Operating Expenses | -$0 | $0 | -$0 | -$1 |
| Operating Expenses | $20 | $17 | $18 | $20 |
| Operating Income | -$6 | -$10 | -$11 | -$17 |
| % Margin | -26.2% | -56.9% | -61.4% | -158% |
| Other Income/Exp. Net | -$1 | -$1 | -$0 | -$8 |
| Pre-Tax Income | -$7 | -$11 | -$11 | -$25 |
| Tax Expense | $0 | -$0 | -$0 | -$7 |
| Net Income | -$7 | -$12 | -$10 | -$16 |
| % Margin | -31.4% | -70.2% | -60% | -155.8% |
| EPS | -0.53 | -0.94 | -0.8 | -1.29 |
| % Growth | 43.6% | -17.5% | 38% | – |
| EPS Diluted | -0.53 | -0.94 | -0.8 | -1.29 |
| Weighted Avg Shares Out | 14 | 13 | 13 | 13 |
| Weighted Avg Shares Out Dil | 14 | 13 | 13 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$11 | -$11 | -$25 |
| % Margin | -28.5% | -61.6% | -63.6% | -237.3% |